Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting

The heart requires nutrients and oxygen carried in the blood to generate energy for healthy pump function. Blood is supplied via heart vessels called coronary arteries. When the arteries narrow the in...

Lead sponsor: Papworth Hospital NHS Foundation Trust•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Stephen P Hoole, BM BCh, MA, DM

CONTACT

01480 364119 [email protected]

Richard G Axell, BEng, MSc

CONTACT

01223 348098 [email protected]

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment30

Start dateSep 2014

Last updatedApr 11, 2016

Condition

Right Coronary Artery Percutaneous Coronary Intervention Right Ventricular Diastolic Dysfunction

Locations shown

Papworth Hospital NHS Foundation Turst

Cambridge, Cambridgeshire

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 11, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions